Literature DB >> 30262577

Development and validation of a simple tool for the assessment of home noninvasive ventilation: the S3-NIV questionnaire.

Elise Dupuis-Lozeron1, Grégoire Gex2,3, Patrick Pasquina3, Pierre-Olivier Bridevaux2,3,4, Jean-Christian Borel5, Paola M Soccal3,4, Wolfram Windisch6,7, Jean-Louis Pépin8,9, Jean-Paul Janssens3,4, Dan Adler3,4.   

Abstract

Patient-centred outcomes are significantly modified by long-term home noninvasive ventilation (NIV), but a short, self-administered, specific tool for routine clinical assessment is lacking. The aim of this study was to develop and validate the S3-NIV questionnaire, a short questionnaire to measure respiratory symptoms, sleep quality and NIV-related side effects.Patients with stable disease who were under long-term home NIV were recruited from three outpatient NIV services. Questionnaire development consisted of a selection of core items for analysis, followed by item reduction, validation and test-retest reliability.338 patients completed a 22-item questionnaire. 11 items were removed because of non-scalability (n=2), redundancy (n=8) and lack of fit (n=1). The final version of the S3-NIV questionnaire consisted of 11 items covering two dimensions: "respiratory symptoms" (Cronbach's α=0.84) and "sleep &amp; NIV-related side effects" (Cronbach's α=0.77). Convergent validity was high between the "respiratory symptoms" subscale of the S3-NIV questionnaire and the St George's Respiratory Questionnaire (rho= -0.76, p<0.001), and between the "sleep &amp; NIV-related side effects" subscale and the Quebec Sleep Questionnaire (rho=0.51, p<0.001). The S3-NIV questionnaire had good test--retest reliability after 4 weeks (intraclass correlation coefficient=0.72).The S3-NIV questionnaire is a short, valid and repeatable self-completed tool for the routine clinical assessment of patients undergoing home NIV.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 30262577     DOI: 10.1183/13993003.011822018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  New Insights in Adherence and Survival in Myotonic Dystrophy Patients Using Home Mechanical Ventilation.

Authors:  Charlotte Seijger; Joost Raaphorst; Judith Vonk; Baziel van Engelen; Harry Heijerman; Nadine Stigter; Peter Wijkstra
Journal:  Respiration       Date:  2021-01-18       Impact factor: 3.580

Review 2.  Teleconsultation in respiratory medicine - A position paper of the Portuguese Pulmonology Society.

Authors:  A Morais; A Bugalho; M Drummond; A J Ferreira; A S Oliveira; S Sousa; J C Winck; J Cardoso
Journal:  Pulmonology       Date:  2022-06-12

Review 3.  Monitoring Long Term Noninvasive Ventilation: Benefits, Caveats and Perspectives.

Authors:  Jean-Paul Janssens; Chloé Cantero; Patrick Pasquina; Marjolaine Georges; Claudio Rabec
Journal:  Front Med (Lausanne)       Date:  2022-05-19

4.  Noninvasive Home Mechanical Ventilation in Adult Myotonic Dystrophy Type 1: A Systematic Review.

Authors:  Bettine A H Vosse; Charlotte Seijger; Nicolle Cobben; Baziel van Engelen; Sander M J van Kuijk; Catharina Faber; Peter Wijkstra
Journal:  Respiration       Date:  2021-05-07       Impact factor: 3.580

5.  The Transitions to Long-term In Home Ventilator Engagement Study (Transitions to LIVE): study protocol for a pragmatic randomized controlled trial.

Authors:  Reshma Amin; Andrea Gershon; Louise Rose; Francine Buchanan; Regina Pizzuti; Adam Qazi; Nishali Patel; Ruxandra Pinto; Myla E Moretti; Munazzah Ambreen
Journal:  Trials       Date:  2022-02-07       Impact factor: 2.279

6.  Impact of Confinement in Patients under Long-Term Noninvasive Ventilation during the First Wave of the SARS-CoV-2 Pandemic: A Remarkable Resilience.

Authors:  Chloé Cantero; Patrick Pasquina; Melissa Dominicé Dao; Christine Cedraschi; Dan Adler; Jérôme Plojoux; Jean-Paul Janssens
Journal:  Respiration       Date:  2021-06-15       Impact factor: 3.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.